CONNECTs
Our programmes
- See All
- Podcast
- Experts knowledge share
- E-learning
- Video
- Publication
- Other
Endocrinology Pediatrics Oncology
Key Publication Snapshot 5: TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
Experts
Dr Luca Toschi-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Downloadable 
5 MIN
Sep 2021 
Oncology Pediatrics Endocrinology
Learn about the patient journey through diagnosis and treatment of NTRK fusion positive cancer
Experts
Prof. Ulrik Lassen, Assoc. Prof. Caterina Marchiò-
5 MIN
-
Sep 2021
-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Current opinions on how to identify and treat NTRK fusion positive cancer
Experts
Prof. David Hong, Prof. Ezra Cohen, Prof. Frédérique Penault-Llorca-
Downloadable
Resouces -
5 MIN
-
Sep 2021
-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Key Publication Snapshot 3 – Characterisation of adverse events caused by TRK inhibitor therapy
Experts
Prof. Ezra Cohen-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Endocrinology Pediatrics Oncology
Key Publication Snapshot 2 – Identifying patients with NTRK fusion cancer
Experts
Prof. Fernando López-Ríos-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Pediatrics Oncology Endocrinology
Highlights BY NTRK CONNECT – Key NTRK fusion abstracts from USCAP, ELCC and AACR 2021
Experts
Dr Fernando Santini-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Pediatrics Oncology Endocrinology
NTRK CONNECT Update from ESMO 2019
Experts
Assoc. Prof. Caterina Marchiò-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Key Publication Snapshot 1 – Larotrectinib and Entrectinib efficacy and safety profile in solid tumours
Experts
Prof. Andrea Sartore-Bianchi-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Pediatrics Oncology Endocrinology
NTRK gene fusions, TRK inhibitors and testing approaches BluePrint
Experts
Prof. Andrea Sartore-Bianchi, Prof. Fernando López-Ríos, Assoc. Prof. Gerald Prager-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Highlights BY NTRK CONNECT – Key NTRK fusion abstracts from ASCO and WCGIC 2021
Experts
Prof. Andrea Sartore-Bianchi-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Oncology
An Experts’ Forum in Tokyo and Singapore on DDR and PARP inhibition
Experts
Prof. Keiichi Fujiwara, Prof. Simon Boulton, Dr Shinji Ohno, Dr Rebecca Dent, Prof. Charlie Gourley-
Downloadable
Resouces -
60 MIN
-
Sep 2021
Oncology
Moving from PARP Inhibition to Targeting DNA Repair and DDR in Cancer Therapy
Experts
Dr Judith Balmaña, Dr Rebecca Dent, Prof. Simon Boulton, Prof. Sibylle Loibl, Prof. Eric Pujade-Lauraine, Prof. Charlie Gourley, Dr Violeta Serra, Prof. Jonathan A. Ledermann-
Downloadable
Resouces -
10 MIN
-
Sep 2021
Video
Oncology
Understand the MoA of PARP inhibitors and targeting DNA Damage Response (DDR)
Experts
Dr Robert L. Coleman, Prof. Simon Boulton-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Interactive e-learning
Oncology
The Role of PARP Inhibition in Clinical Practice
Experts
Prof. Jonathan A. Ledermann, Dr Rebecca Dent, Dr Robert L. Coleman, Prof. Eric Pujade-Lauraine-
60 MIN
-
Sep 2021
Other
Oncology
The Role of DDR and PARP inhibition (PARPi) in Oncology – BluePrints
Experts
Dr Violeta Serra, Prof. Jonathan A. Ledermann, Prof. Eric Pujade-Lauraine, Prof. Simon Boulton, Dr Mark J. O'Connor, Prof. Charlie Gourley, Dr Judith Balmaña, Prof. Sibylle Loibl-
Downloadable
Resouces -
MIN
-
Sep 2021
Oncology
PARP inhibition and DNA Damage Response (DDR)
This comprehensive resource looks at PARP inhibition and DDR as therapeutic targets across multiple tumour types
Experts
Prof. Simon Boulton, Dr Violeta Serra, Dr Judith Balmaña, Prof. Charlie Gourley-
30 MIN
-
Oct 2021
Oncology
Update From ASCO 2022 – Selected LBAs
COR2ED brings you an update on the late breaker plenary sessions from ASCO 2022
Experts
Dr Rebecca Dent, Prof. Chiara Cremolini, Asst. Prof. Hans Lee, Prof. Jonathan Trent-
7 MIN
-
May 2022
Oncology
COR2ED at ESMO 2022
We celebrate our 10-year anniversary at the COR2ED booth during ESMO 2022. In 10 years, 500,000 healthcare professionals have trusted our educational programmes.
-
2 MIN
-
Sep 2022
-
Downloadable
Resouces -
5 MIN
-
Sep 2022
Oncology
Update From San Antonio Breast Cancer Symposium 2022
COR2ED presents an update on selected General Sessions from SABCS 2022
Experts
Dr Santiago Escrivá de Romaní-
5 MIN
-
Dec 2022
Conference update
Episode
1
of 6
Oncology Obstetrics and Gynecology Hemato-oncology
Listen to Expert Insights on Late-Breaking Data from ASCO 2023
Episode 1: Non-Small-Cell Lung Cancer Update: ADAURA trial
Experts
Dr Mansoor Raza Mirza, Dr Paolo Tarantino, Prof. Alexey V Danilov, Prof. Mark Socinski, Prof. Evan Yu, Prof. Thomas Powles, Assoc. Prof. Gerald Prager-
2 MIN
-
Jun 2023
Video
Episode
1
of 4
Oncology
New Oral Endocrine Therapy Options for Patients with Advanced or Metastatic ER+ Breast Cancer
Episode 1: Overview of Clinical Data of SERDs & Their Place in Treatment Landscape
Experts
Dr Sara Tolaney, Dr Aditya Bardia, Prof. Frédérique Penault-LlorcaEndorsed by
-
Downloadable
Resouces -
18 MIN
-
Jul 2023
Podcast
Episode
1
of 3
Oncology
Oral SERDs in ER+ breast cancer
Episode 1: Efficacy, safety and treatment landscape
Experts
Prof. Shaheenah Dawood, Assoc. Clinical Professor Rena CallahanEndorsed by
-
23 MIN
-
Jul 2023
Interactive patient case
Episode
1
of 2
Oncology
Oral SERDs: New Endocrine Therapy Options in ER+ Advanced or Metastatic Breast Cancer – Part 1
An interactive patient case video series from breast cancer specialists
Experts
Dr Elisa AgostinettoEndorsed by
-
15 MIN
-
Sep 2023
Video
Oncology
Navigating the ER+ Breast Cancer Journey: Oral SERDs and the Treatment Landscape
Follow a patient's breast cancer journey from diagnosis to treatment options
Experts
Prof. Francois-Clement BidardEndorsed by
-
Downloadable
Resouces -
7 MIN
-
Oct 2023
Interactive patient case
Episode
2
of 2
Oncology
Oral SERDs: New Endocrine Therapy Options in ER+ Advanced or Metastatic Breast Cancer – Part 2
An interactive patient case video series from breast cancer specialists
Experts
Prof. Valentina GuarneriEndorsed by
-
15 MIN
-
Oct 2023